Correction: International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape [0.03%]
纠正：转移性胃癌的治疗国际共识：雾霭景观中的逐步推进
Paolo Morgagni,Maria Bencivenga,Fatima Carneiro et al.
Paolo Morgagni et al.
Comment on: Statin use in relation to long-term survival after gastrectomy for gastric adenocarcinoma: a Swedish population-based cohort study [0.03%]
他汀类药物的使用与胃腺癌根治术后长期生存关系的瑞典队列研究述评
Abeer Tariq,Rimsha Ijaz,Fnu Samiullah
Abeer Tariq
Correction: Addition of docetaxel to S-1 results in significantly superior 5-year survival outcomes in Stage III gastric cancer: a final report of the JACCRO GC-07 study [0.03%]
纠正：在S-1中加入多西他赛可显著改善III期胃癌患者的五年生存率：JACCRO GC-07研究最终报告
Yasuhiro Kodera,Kazuhiro Yoshida,Mitsugu Kochi et al.
Yasuhiro Kodera et al.
Bemarituzumab plus mFOLFOX6 as first-line treatment in East Asian patients with FGFR2b-overexpressing locally advanced or metastatic gastric/gastroesophageal junction cancer: subgroup of FIGHT final analysis [0.03%]
Bemarituzumab联合mFOLFOX6用于FGFR2b高表达的局部晚期或转移性胃/胃食管交界癌一线治疗：FIGHT最终分析的东亚人群亚组结果
Yoon-Koo Kang,Shukui Qin,Keun-Wook Lee et al.
Yoon-Koo Kang et al.
Background: In the FIGHT study (NCT03694522) bemarituzumab, a humanized monoclonal antibody selective for fibroblast growth factor receptor 2b (FGFR2b), plus mFOLFOX6 showed clinically meaningful efficacy in patients with...
Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors for new-onset gastric cancer and gastric diseases in patients with type 2 diabetes mellitus: a population-based cohort study [0.03%]
钠葡萄糖共转运蛋白-2抑制剂对2型糖尿病患者新发胃癌和胃病的疗效比较：基于人群的队列研究
Oscar Hou In Chou,Vinod Kumar Chauhan,Cheuk To Skylar Chung et al.
Oscar Hou In Chou et al.
Objective: To compare the risks of gastric cancer and other gastric diseases in patients with type-2 diabetes mellitus (T2DM) exposed to sodium-glucose cotransporter 2 inhibitors (SGLT2I), dipeptidyl peptidase-4 inhibitor...
TMEM205 induces TAM/M2 polarization to promote cisplatin resistance in gastric cancer [0.03%]
TMEM205通过诱导TAM/M2极化促进胃癌细胞顺铂耐药性
Qiang Fu,Xuwei Wu,Zhongqi Lu et al.
Qiang Fu et al.
Cisplatin (DDP) is a basic chemotherapy drug for gastric cancer (GC). With the increase of DDP drug concentration in clinical treatment, cancer cells gradually became resistant. Therefore, it is necessary to find effective therapeutic targe...
CDKN2A somatic copy number amplification in normal tissues surrounding gastric carcinoma reduces cancer metastasis risk in droplet digital PCR analysis [0.03%]
邻近胃癌周围正常组织中CDKN2A体细胞拷贝数扩增可降低癌症转移风险（基于微滴数字PCR分析）
Lewen Deng,Jing Zhou,Yu Sun et al.
Lewen Deng et al.
Background: The CDKN2A gene is frequently affected by somatic copy number variations (SCNVs, including deletions and amplifications [SCNdel and SCNamp]) in the cancer genome. Using surgical gastric margin tissue samples (...
Impact of chemotherapy delay on long-term prognosis of laparoscopic radical surgery for locally advanced gastric cancer: a pooled analysis of four randomized controlled trials [0.03%]
化疗延迟对局部进展期胃癌腹腔镜根治术长期预后影响的Meta分析研究
Qing Zhong,Zhi-Yu Liu,Zhi-Xin Shang-Guan et al.
Qing Zhong et al.
Background: Adjuvant chemotherapy following curative surgery for locally advanced gastric cancer (AGC) significantly improves long-term patient prognosis. However, delayed chemotherapy (DC), in which patients are unable t...
Janus kinase inhibitor overcomes resistance to immune checkpoint inhibitor treatment in peritoneal dissemination of gastric cancer in C57BL/6 J mice [0.03%]
Janus激酶抑制剂可克服C57BL/6 J小鼠胃癌腹膜扩散免疫检查点抑制剂治疗耐药性
Wan-Ying Du,Hiroki Masuda,Koji Nagaoka et al.
Wan-Ying Du et al.
Background: Cancer immunotherapy aims to unleash the immune system's potential against cancer cells, providing sustained relief for tumors responsive to immune checkpoint inhibitors (ICIs). While promising in gastric canc...
CTNND1 is involved in germline predisposition to early-onset gastric cancer by affecting cell-to-cell interactions [0.03%]
CTNND1通过影响细胞间相互作用参与遗传性早期胃癌发病机制
Cristina Herrera-Pariente,Laia Bonjoch,Jenifer Muñoz et al.
Cristina Herrera-Pariente et al.
Background: CDH1 and CTNNA1 remain as the main genes for hereditary gastric cancer. However, they only explain a small fraction of gastric cancer cases with suspected inherited basis. In this study, we aimed to identify n...